Clinical and pathologic findings of spitz nevi and atypical spitz tumors with ALK fusions

American Journal of Surgical Pathology

Volumn 38, Issue 7, 2014, Pages 925-933

  Busam, Klaus J ^a   Kutzner, Heinz ^b   Cerroni, Lorenzo ^c   Wiesner, Thomas ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Dermatopathologie Friedrichshafen   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

ALK; kinase fusion; melanocytic nevus; Spitz nevus

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; DYNACTIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN TYROSINE KINASE; TPM3 PROTEIN, HUMAN; TROPOMYOSIN; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; BIOPSY; CHILD; COPY NUMBER VARIATION; ENZYMOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE FUSION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; NEVUS; PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SKIN TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; BIOPSY; CHILD; CHILD, PRESCHOOL; DNA COPY NUMBER VARIATIONS; FEMALE; GENE DOSAGE; GENE FUSION; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEVUS, EPITHELIOID AND SPINDLE CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; SKIN NEOPLASMS; TROPOMYOSIN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84902553900     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000187     Document Type: Article

References (26)

1. Zedek DC, McCalmont TH. Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma. Clin Lab Med. 2011;31: 311-320.
2. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157: 967-972.
3. Bastian BC, Wesselmann U, Pinkel D, et al. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999;113: 1065-1069.
4. Fullen DR, et al. BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol. 2006;19: 1324-1332.
5. Gerami P, Busam KJ. Cytogenetic and mutational analyses of melanocytic tumors. Dermatol Clin. 2012;30: 555-566.
6. Gerami P, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013;37: 676-684.
7. Murali R, et al. GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol. 2012;123: 457-459.
8. Busam KJ, et al. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes. Am J Surg Pathol. 2013;37: 193-199.
9. Busam KJ, Wanna M, Wiesner T. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. JAMA Dermatol. 2013;149: 335-339.
10. Wiesner T, He J, Yelensky R, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014;5:3116.
11. Van Raamsdonk CD, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010;363: 2191-2199.
12. van Dijk MC, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma. Am J Surg Pathol. 2005; 29: 1145-1151.
13. Fang Y, et al. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status. Int J Surg Pathol. 2012; 20: 434-440.
14. Gerami P, et al. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol. 2009;33: 1783-1788.
15. Gerami P, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009;33: 1146-1156.
16. Spitz S. Melanomas of childhood. Am J Pathol. 1948;24: 591-609.
17. Ackerman AB. Spitz nevus. Am J Dermatopathol. 1997;19: 419-421.
18. Dahlstrom JE, et al. Spitz naevus: diagnostic problems and their management implications. Pathology. 2004;36: 452-457.
19. LeBoit P. Spitz nevus: a look back and a look ahead. Adv Dermatol. 2000;16:81-109; discussion 110.
20. Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment. Mod Pathol. 2006;19(suppl 2):S21-S33. (Pubitemid 43172307)
21. Connors RC, Chalet MD, Ackerman AB. Benign juvenile melanoma (Spitz nevus) vs. superficial spreading malignant melanoma: criteria for histologic differentiation. J Dermatol Surg. 1975;1: 14-15.
22. Spatz A, Barnhill RL. The Spitz tumor 50 years later: revisiting a landmark contribution and unresolved controversy. J Am Acad Dermatol. 1999;40(pt 1): 223-228.
23. Gerami P, et al. Outcomes of atypical Spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. Am J Surg Pathol. 2013;37: 1387-1394.
24. McCalmont TH, et al. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011;38:324-326. 323.
25. Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther. 2006;19: 40-49.
26. Wiesner T, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36: 818-830.